Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Pomalidomide

EU orphan designation number: EU/3/09/672   
Active ingredient: Pomalidomide
Indication: Treatment of multiple myeloma
Sponsor: Celgene Europe Limited
1 Longwalk Road, Stockley Park, Uxbridge, Middlesex UB11 1DB, United Kingdom
EU Centralised marketing authorisation: A centralised EU marketing authorisation has been obtained under the name Imnovid on 05/08/2013 with the number EU/1/13/850

   Public summary of scientific opinion     EPAR

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/10/2009 Centralised Orphan - Designation EMEA/OD/053/09 (2009)7847 of 08/10/2009
30/05/2011 Other procedure EMEA/OD/053/09